BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 10655513)

  • 1. Overexpression of M68/DcR3 in human gastrointestinal tract tumors independent of gene amplification and its location in a four-gene cluster.
    Bai C; Connolly B; Metzker ML; Hilliard CA; Liu X; Sandig V; Soderman A; Galloway SM; Liu Q; Austin CP; Caskey CT
    Proc Natl Acad Sci U S A; 2000 Feb; 97(3):1230-5. PubMed ID: 10655513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent gene amplification and overexpression of decoy receptor 3 in glioblastoma.
    Arakawa Y; Tachibana O; Hasegawa M; Miyamori T; Yamashita J; Hayashi Y
    Acta Neuropathol; 2005 Mar; 109(3):294-8. PubMed ID: 15627206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hepatocyte nuclear factor 3 alpha gene, HNF3alpha (FOXA1), on chromosome band 14q13 is amplified and overexpressed in esophageal and lung adenocarcinomas.
    Lin L; Miller CT; Contreras JI; Prescott MS; Dagenais SL; Wu R; Yee J; Orringer MB; Misek DE; Hanash SM; Glover TW; Beer DG
    Cancer Res; 2002 Sep; 62(18):5273-9. PubMed ID: 12234996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal growth factor receptor overexpression/amplification in adenocarcinomas arising in the gastrointestinal tract.
    Rossi E; Villanacci V; Danesino C; Donato F; Nascimbeni R; Bassotti G
    Rev Esp Enferm Dig; 2011 Dec; 103(12):632-9. PubMed ID: 22217347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Overexpression and genomic amplification of decoy receptor 3 in hepatocellular carcinoma and significance thereof].
    Shen HW; Wu YL; Peng SY
    Zhonghua Yi Xue Za Zhi; 2003 May; 83(9):744-7. PubMed ID: 12899749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of decoy receptor 3 in hepatocellular carcinoma and its association with resistance to Fas ligand-mediated apoptosis.
    Shen HW; Gao SL; Wu YL; Peng SY
    World J Gastroenterol; 2005 Oct; 11(38):5926-30. PubMed ID: 16273601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic significance of overexpression of the decoy receptor for Fas ligand (DcR3) in patients with gastric carcinomas.
    Takahama Y; Yamada Y; Emoto K; Fujimoto H; Takayama T; Ueno M; Uchida H; Hirao S; Mizuno T; Nakajima Y
    Gastric Cancer; 2002; 5(2):61-8. PubMed ID: 12111580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DCR3 locus is a predictive marker for 5-fluorouracil-based adjuvant chemotherapy in colorectal cancer.
    Mild G; Bachmann F; Boulay JL; Glatz K; Laffer U; Lowy A; Metzger U; Reuter J; Terracciano L; Herrmann R; Rochlitz C
    Int J Cancer; 2002 Nov; 102(3):254-7. PubMed ID: 12397645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer.
    Pitti RM; Marsters SA; Lawrence DA; Roy M; Kischkel FC; Dowd P; Huang A; Donahue CJ; Sherwood SW; Baldwin DT; Godowski PJ; Wood WI; Gurney AL; Hillan KJ; Cohen RL; Goddard AD; Botstein D; Ashkenazi A
    Nature; 1998 Dec; 396(6712):699-703. PubMed ID: 9872321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosome arm 20q gains and other genomic alterations in esophageal squamous cell carcinoma, as analyzed by comparative genomic hybridization and fluorescence in situ hybridization.
    Fujita Y; Sakakura C; Shimomura K; Nakanishi M; Yasuoka R; Aragane H; Hagiwara A; Abe T; Inazawa J; Yamagishi H
    Hepatogastroenterology; 2003; 50(54):1857-63. PubMed ID: 14696419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The antiapoptotic decoy receptor TRID/TRAIL-R3 is a p53-regulated DNA damage-inducible gene that is overexpressed in primary tumors of the gastrointestinal tract.
    Sheikh MS; Huang Y; Fernandez-Salas EA; El-Deiry WS; Friess H; Amundson S; Yin J; Meltzer SJ; Holbrook NJ; Fornace AJ
    Oncogene; 1999 Jul; 18(28):4153-9. PubMed ID: 10435597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The human TDE gene homologue: localization to 20q13.1-13.3 and variable expression in human tumor cell lines and tissue.
    Bossolasco M; Lebel M; Lemieux N; Mes-Masson AM
    Mol Carcinog; 1999 Nov; 26(3):189-200. PubMed ID: 10559794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coamplification in tumors of KRAS2, type 2 inositol 1,4,5 triphosphate receptor gene, and a novel human gene, KRAG.
    Heighway J; Betticher DC; Hoban PR; Altermatt HJ; Cowen R
    Genomics; 1996 Jul; 35(1):207-14. PubMed ID: 8661122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amplification and overexpression of the dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 (DYRK2) gene in esophageal and lung adenocarcinomas.
    Miller CT; Aggarwal S; Lin TK; Dagenais SL; Contreras JI; Orringer MB; Glover TW; Beer DG; Lin L
    Cancer Res; 2003 Jul; 63(14):4136-43. PubMed ID: 12874018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of detecting elevated serum DcR3/TR6/M68 in malignant tumor patients.
    Wu Y; Han B; Sheng H; Lin M; Moore PA; Zhang J; Wu J
    Int J Cancer; 2003 Jul; 105(5):724-32. PubMed ID: 12740925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous decoy receptor 3 blocks the growth inhibition signals mediated by Fas ligand in human pancreatic adenocarcinoma.
    Tsuji S; Hosotani R; Yonehara S; Masui T; Tulachan SS; Nakajima S; Kobayashi H; Koizumi M; Toyoda E; Ito D; Kami K; Mori T; Fujimoto K; Doi R; Imamura M
    Int J Cancer; 2003 Aug; 106(1):17-25. PubMed ID: 12794752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ERBB2 amplifications in esophageal adenocarcinoma.
    Dahlberg PS; Jacobson BA; Dahal G; Fink JM; Kratzke RA; Maddaus MA; Ferrin LJ
    Ann Thorac Surg; 2004 Nov; 78(5):1790-800. PubMed ID: 15511476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and characterization of a 19q12 amplicon in esophageal adenocarcinomas reveals cyclin E as the best candidate gene for this amplicon.
    Lin L; Prescott MS; Zhu Z; Singh P; Chun SY; Kuick RD; Hanash SM; Orringer MB; Glover TW; Beer DG
    Cancer Res; 2000 Dec; 60(24):7021-7. PubMed ID: 11156406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis.
    Yu KY; Kwon B; Ni J; Zhai Y; Ebner R; Kwon BS
    J Biol Chem; 1999 May; 274(20):13733-6. PubMed ID: 10318773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A minimal critical region of the 8p22-23 amplicon in esophageal adenocarcinomas defined using sequence tagged site-amplification mapping and quantitative polymerase chain reaction includes the GATA-4 gene.
    Lin L; Aggarwal S; Glover TW; Orringer MB; Hanash S; Beer DG
    Cancer Res; 2000 Mar; 60(5):1341-7. PubMed ID: 10728696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.